Crystal structure of vinblastine

Journal of the Chemical Society, Perkin Transactions 1

Volumn , Issue 13, 2000, Pages 2079-2082

  Bau, Robert ^a   Jin, Kevin Kai ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATIONS; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIFFUSION; DRUG PRODUCTS; MOLECULAR STRUCTURE; X RAY CRYSTALLOGRAPHY;

MOLECULAR GEOMETRIES;

AROMATIC HYDROCARBONS;

EID: 0034617312     PISSN: 14704358     EISSN: None     Source Type: Journal    
DOI: 10.1039/b001855o     Document Type: Article

References (28)

1. For a comprehensive review, see; The Alkaloids: Antitumor Bisindole Alkaloids from Catharanthus Roseus, eds. A. Brossi and M. Suffness, Academic Press, New York, vol. 37, 1990.
2. R. L. Noble, C. T. Beer and J. H. Cutts, Ann. N.Y. Acad. Sci., 1958, 76, 882.
3. R. H. Himes, Pharmacol. Ther., 1991, 51, 257.
4. By binding to the protein tubulin with high affinity, the vinca alkaloids inhibit microtubule assembly (they prevent cells from making the spindles needed to pull the chromosomes apart during cell division). This action is similar to that of colchicine, but is different from that of taxol, which also binds to tubulin but interferes with cell division in an opposite way, by preventing the spindles from being broken down.
5. (a) J. W. Moncrief and W. N. Lipscomb, J. Am. Chem. Soc., 1965, 87, 4963
6. (b) J. W. Moncrief and W. N. Lipscomb, Acta Crystallogr., 1966, 21, 322.
7. (a) An unpublished account of an X-ray structure determination of a different salt of the title compound (vinblastine dihydrochloride) has been mentioned in reference 6(b) as footnote 19 ("O. Kennard and J. Nachman, unpublished observations"), but no details were given other than the fact that the C17′-C18′-C15-C16 dihedral angle in that molecule had a value of 165°
8. (b) B. K. Hunter, L. D. Hall and J. K. M. Sanders, J, Chem. Soc., Perkin Trans. 1, 1983, 657.
9. (a) Crystallization of Nucleic Acids and Proteins, eds., A. Ducruix and R. Giegé, Oxford University Press, Oxford, UK, 1992
10. (b) Protein Crystallization: Techniques, Strategies and Tips, ed. T. M. Bergfors, International University Line Press, Oxford, UK, 1999.
11. (a) R. Bau, J. Am. Chem. Soc., 1998, 120, 9380
12. (b) R. Bau and I. Tsyba, Tetrahedron, 1999, 55, 14839.
13. (a) G. M. Sheldrick, SHELXS-86, University of Göttingen, Germany, 1986
14. (b) G. M. Sheldrick, SHELX-76, University of Cambridge, England, 1976.
15. 18 position is inverted (V. M. Lynch, A. Stamford, P. Magnus and B. E. David, Acta Crystallogr., Sect. C, 1991, 47, 1563.
16. C. W. Andrews, J. Wisowaty, A. O. Davis, R. Crouch and G. E. Martin, J. Heterocycl. Chem., 1995, 32, 1011.
17. 5
18. Peaks corresponding to H positions were found 0.95 Å from N6′ (peak H58) and 1.16 Å from N9 (peak H57). This not only indicates that both nitrogen atoms are protonated, but it also suggests that the hydrogen bond between N9 and the C3 hydroxy group is of the type N9-H ⋯ O27 and not N9 ⋯ H-O27.
19. (a) M. M. Teeter, Proc. Nat. Acad. Sci. USA, 1984, 81, 6014
20. (b) M. Frey, Acta Crystalllogr., Sect. D, 1994, 50, 663.
21. (a) M. E. Kuehne and I. Marko, in The Alkaloids, eds. A. Brossi and M. Suffness, Academic Press, New York, 1990, vol. 37, p. 77
22. (b) P. Potier, D. Guénard and F. Zavala, C. R. Soc. Biol, 1979, 173, 414.
23. (a) L. S. Borman and M. Kuehne, in The Alkaloids, eds. A. Brossi and M. Suffness, Academic Press, New York, 1990, vol. 37, p. 133
24. (b) L. S. Borman, W. G. Bornmann and M. E. Kuehne, Cancer Chemother. Pharmacol., 1993, 31, 343.
25. J. G. Dong, W. Bornmann, K. Nakanishi and N. Berova, Phytochemistry, 1995, 40, 1821.
26. E. Gageelli, G. Valensin, N. J. Stolowich, H. J. Williams and A. I. Scott, J. Nat. Prod., 1992, 55, 285.
27. See reference 3 in: P. Magnus, M. Ladlow and J. Elliott, J. Am. Chem. Soc., 1987, 109, 7929.
28. E. Nogales, S. G. Wolf and K. H. Downing, Nature, 1998, 391, 199.